Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in the company's own shares executed on August 14, 2025, and announced on August 15, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 1,399,293 ordinary shares for cancellation.
- Price Range: Highest price paid was 360.40 pence; lowest was 356.70 pence.
- Volume Weighted Average Price: 358.7136 pence per share.
- Share Capital Post-Transaction: 8,974,906,495 ordinary shares of £0.01 each.
- Treasury Shares: 3,880,205 shares held as treasury shares.
- Voting Shares: 8,971,026,290 ordinary shares with voting rights.
Material Changes
The primary material change is the reduction of the company's share count due to the cancellation of 1,399,293 shares under the second tranche of the share buyback programme announced on July 31, 2025. This transaction reduces the number of shares with voting rights.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the buyback programme. The filing includes a standard disclaimer that the announcement does not constitute an offer or solicitation of an offer for securities. No specific guidance, risks, or contingencies regarding future operations are detailed in this specific report.
Investor Verification Checklist
- Verify the total number of shares repurchased under the full second tranche of the buyback programme announced on July 31, 2025.
- Confirm the remaining authorized buyback limit and the programme's end date.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction data.
- Check subsequent filings for updated financial performance metrics not included in this transaction-specific report.